Drug Database
Back to search

Belgium· BE-AMP-SAM447084-00

Incresync 12.5 mg - 30 mg

A pioglitazone and alogliptin product containing alogliptin benzoate, registered in Belgium by Takeda Pharma. The same ATC class is registered in 9 of our 19 countries.

ATC A10BD09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIncresync 12.5 mg - 30 mgATCA10BD09REGISTER NO.BE-AMP-SAM447084-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alogliptin benzoateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pioglitazone and alogliptin is registered in 9 of 19 countries.

Countries holding a registration under ATC A10BD09 (pioglitazone and alogliptin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search pioglitazone and alogliptin products by name

Pioglitazone and alogliptin · ATC A10BD09

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Alogliptin Benzoate
Manufacturer
Takeda Pharma
Country
Belgium (BE)
ATC code
A10BD09
ATC class
Pioglitazone and alogliptin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pioglitazone and alogliptin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pioglitazone and alogliptin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a4f41a98-afea-4491-b17f-047d05787dbb
GET /v1/drugs/a4f41a98-afea-4491-b17f-047d05787dbb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Incresync 12.5 mg - 30 mg",
  "name_fr": "Incresync 12.5 mg - 30 mg",
  "name_nl": "Incresync 12.5 mg - 30 mg",
  "amp_code": "SAM447084-00",
  "strengths": [
    "12.5000",
    "30.0000"
  ],
  "pack_count": 9,
  "substances": [
    "Alogliptin Benzoate",
    "Alogliptin",
    "Pioglitazone Hydrochloride",
    "Pioglitazone",
    "Lactose Monohydrate",
    "Mannitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Pioglitazone and Alogliptin",
  "authorisation_numbers": [
    "EU/1/13/842/001",
    "EU/1/13/842/002",
    "EU/1/13/842/004",
    "EU/1/13/842/003",
    "EU/1/13/842/006",
    "EU/1/13/842/005",
    "EU/1/13/842/008",
    "EU/1/13/842/007",
    "EU/1/13/842/009"
  ]
}
API referenceMCP serverPlans

See everything about pioglitazone and alogliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console